Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Eicosapentaenoic acid pre-treatment reduces biochemical changes induced in total brain and myelin of weanling Wistar rats by cuprizone feeding.
USPIO-Enhanced MRI Neuroimaging: A Review.
Hit-to-lead evaluation of a novel class of sphingosine 1-phosphate lyase inhibitors.
Optical coherence tomography indicates disease activity prior to clinical onset of central nervous system demyelination.
Targeted mutations in Val101 and Arg27 interferon beta protein increase its transcriptional and translational activities.
Post-CNS-inflammation expression of CXCL12 promotes the endogenous myelin/neuronal repair capacity following spontaneous recovery from multiple sclerosis-like disease.
EOP, a Newly Synthesized Ethyl Pyruvate Derivative, Attenuates the Production of Inflammatory Mediators via p38, ERK and NF-κB Pathways in Lipopolysaccharide-Activated BV-2 Microglial Cells.
Regenerative Medicines for Remyelination: From Aspiration to Reality.
Inflammation negatively regulates FOXP3 and regulatory T-cell function via DBC1.
The Clinical Characteristics of Primary Sjogren's Syndrome With Neuromyelitis Optica Spectrum Disorder in China: A STROBE-Compliant Article.
Pharmaceutical approval update.
Helicobacter pylori infection might prove the hygiene hypothesis in multiple sclerosis.
Management of neurogenic lower urinary tract dysfunction in multiple sclerosis patients.
Brain MRI lesions and atrophy are associated with employment status in patients with multiple sclerosis.
Macrophage-Targeted Therapy: CD64-Based Immunotoxins for Treatment of Chronic Inflammatory Diseases.
Glatiramer Acetate in Treatment of Multiple Sclerosis: A Toolbox of Random Co-Polymers for Targeting Inflammatory Mechanisms of both the Innate and Adaptive Immune System?
Immunoglobulin GM allotypes in multiple sclerosis.
Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis-osteopontin as a potential marker of clinical severity.
Circulating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosis.
Anxiety state affects information processing speed in patients with multiple sclerosis.
Immunoablation of cells expressing the NG2 chondroitin sulphate proteoglycan.
Attributional style and depression in multiple sclerosis: the learned helplessness model.
Development of a Human Dihydroorotate Dehydrogenase (hDHODH) Pharma-Similarity Index Approach with Scaffold-Hopping Strategy for the Design of Novel Potential Inhibitors.
Does fatigue complaint reflect memory impairment in multiple sclerosis?
Month of birth and the incidence of multiple sclerosis in southern iran.

Pages